6 August 2020 (Thursday) - Transfusion News Email


The nice people at Transfusion News sent me quite a lot to think about today. As I said yesterday about something else, pretty much all COVID-19 related, but I’m not complaining. It is good of them to do what they do for me, and all for free…

Convalescent Plasma Is Safe and Likely Efficacious for Patients with COVID-19

August 4, 2020
There are limited therapeutic options to treat COVID-19, and COVID-19 convalescent plasma (CCP) is currently one of the most common treatments for patients infected with SARS-CoV-2. However, limited data on efficacy have been available. Additional data in support of the safety and efficacy of convalescent plasma from [Read More]


Studies Find Variable Anti-SARS-CoV-2 Antibody Responses

July 29, 2020
Three recent studies have analyzed anti-SARS-CoV-2 antibodies among individuals with asymptomatic and mild SARS-CoV-2 infections, and they have found that antibody responses are variable and short lived. In 37 asymptomatic, RT-PCR positive cases in China (median age 41 years, 40% male), anti-spike protein IgG levels were significantly [Read More]

No comments:

Post a comment